Actively Recruiting
Study of Neoadjuvant Intense Endocrine Therapy Before Prostatectomy in High Risk and Locally Advanced Prostate Cancer
Led by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Updated on 2022-08-16
900
Participants Needed
1
Research Sites
182 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of different types of neoadjuvant intense androgen deprivation therapy ADT compared to ADT alone in men with high-risk or locally advanced prostate cancer. This phase 2, prospective, multicenter clinical trial aims to find the best pre-surgery hormone treatment to improve outcomes before prostate removal. The study focuses on men eligible for prostatectomy with specific tumor characteristics or lymph node involvement. Participants receive one of several treatment combinations for six cycles of 28 days each before undergoing robot-assisted radical prostatectomy within two weeks after completing therapy. Treatment groups include ADT alone or ADT combined with drugs such as abiraterone acetate, prednisolone, enzalutamide, apalutamide, darotamide, rezvilutamide, and PARP inhibitors. Some groups receive PARP inhibitors with or without abiraterone, and patients with specific gene mutations are included in these groups. During the study, participants will be monitored for treatment response using pathologic evaluation and biochemical progression over up to three years. Additional measures include metastasis-free survival, time to castration-resistant prostate cancer, PSA response, surgical margin status, and adverse events over five years. Researchers will assess patient health with physical scores and organ function tests. Participants will be followed long term to evaluate safety and treatment outcomes.
CONDITIONS
Brief Title
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here